Genomic Valley Biotech Ltd — Updates, 30-05-2025: Company Update

Genomic Valley Biotech has announced a board meeting on which approved the financial results for the quarter and half-year and the year ended March 31, 2025. The company reported total revenue of ₹84.84 lakh with expenses of ₹48.56 lakh, resulting in a profit before tax of ₹35.61 lakh. It also appointed Mr. Yogainder Kumar Gupta as an Additional Independent Director for five years and engaged M/s. SBR & Co. LLP as Secretarial Auditors for FY 2024-25. The board restructured key committees including Audit, Stakeholders’ Relationship, Nomination & Remuneration, and Risk Management, reflecting governance enhancement.